Sarah Safadi

Appearances

LYNCH SYNDROME (LS) PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) HAVE SIGNIFICANTLY HIGHER INTESTINAL NEOPLASIA RISK THAN LS PATIENTS WITHOUT IBD
Date
May 20, 2024
Background & Aims: Inflammatory bowel disease (IBD) and Lynch syndrome (LS) are both risk factors for colorectal cancer (CRC), however it is unclear if those with LS+IBD have compounded cancer risk or if they would benefit from more intensive surveillance…
Presenter
Timothy Yen
Speakers
Abigail Braun
Frank Scott
University of Colorado Anschutz Medical Campus
Nicole Doria
Sarah Safadi
Swati Patel
University of Colorado, Rocky Mountain Regional VA